| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 07/14/2004 | CN2624618Y Special cage for pet mice |
| 07/14/2004 | CN1511599A High energy array magnetic core of biological magnetic field regulation |
| 07/14/2004 | CN1511450A Biological preventing and controlling of American white moth by chouioia cunea yang |
| 07/14/2004 | CA2455052A1 Cricket habitat and retail receptacle |
| 07/13/2004 | US6762291 Used to modify insects and worms, or cultured cells, resulting in p53 expression or mis-expression; modified organisms or cells are used in screening assays to identify potential pesticidal agents or therapeutics that interact with p53 |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/08/2004 | WO2004057028A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene |
| 07/08/2004 | WO2004056857A2 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes |
| 07/08/2004 | WO2004056856A1 Inactive transcription factor tif-ia and uses thereof |
| 07/08/2004 | WO2004044150A3 Systems for gene targeting and producing stable genomic transgen e insertions |
| 07/08/2004 | WO2004042361A3 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 07/08/2004 | WO2004034778A3 Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same |
| 07/08/2004 | WO2004027032A3 Stearoyl coa desaturase transgenic non-human animals |
| 07/08/2004 | WO2004015081A3 Methods for treating circadian rhythm phase disturbances |
| 07/08/2004 | WO2003079757A3 Hiv therapeutic |
| 07/08/2004 | US20040133943 Characterisation of gene function using double stranded RNA inhibition |
| 07/08/2004 | US20040133935 Preparation method of donor cell for nuclear transfer using electro-stimulation and membrane antigen marker and production method of clone animal |
| 07/08/2004 | US20040133932 Genetically engineered mammal for use as bioreactor in expression of heterologous proteins and blood coagulation factors in milk |
| 07/08/2004 | US20040133931 Using electrical pulsation to simultaneously fuse and activate oocytes comprising transfered nucleus; cloning nonhuman mammal |
| 07/08/2004 | US20040133930 Production of high levels of transgenic factor ix without gene rescue, and its therapeutic uses |
| 07/08/2004 | US20040133114 Zebrafish Assay |
| 07/08/2004 | US20040132182 Use of EDG2 receptor in an animal model of heart failure |
| 07/08/2004 | US20040132058 NPC1L1 (NPC3) and methods of use thereof |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/07/2004 | EP1434988A1 Transgenic knockouts of bace-1 |
| 07/07/2004 | EP1434866A2 Genes associated with mast cell activation |
| 07/07/2004 | EP1434865A2 Variants and exons of the glyt1 transporter |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434598A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 07/07/2004 | EP1434592A1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer |
| 07/07/2004 | EP1434483A2 NUCLEIC ACIDS ENCODING LINKED CHROMO/FLUORESCENT DOMAINS AND METHODS FOR USING THE SAME |
| 07/07/2004 | CN1510139A Human auricular fibrillation pathogenic gene, encoding protein and use thereof |
| 07/07/2004 | CN1509603A Technology for feeding maggots as food to culture young crabs |
| 07/06/2004 | US6759568 Nucleotide sequence coding polypeptide for use in the treatment of thrombosis |
| 07/06/2004 | US6759210 Compositions and methods for the treatment and diagnosis of cardiovascular disease using fehd545 as a target |
| 07/06/2004 | US6759194 Nucleotide sequences encoding peroxisome-associated polypeptides, and their uses in the diagnosis and/or treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 07/06/2004 | US6759038 Evaluating drug for prevention of cancer propagation; administer drug to vertebrate, monitor cancer propagation by fluoresence, compare to control, decrease in fluoresence indicates prevention of tumor propagation |
| 07/01/2004 | WO2004055206A1 Method for generating a genetically modified organism for screening active substances |
| 07/01/2004 | WO2004055186A1 Guanosine triphosphate-binding protein-coupled receptor |
| 07/01/2004 | WO2004054436A2 Calcium-independent phospholipase a2 induces ischemic ventricular arrhythmias and decreases infarction size |
| 07/01/2004 | WO2004054357A1 Methods and vectors for making knockout animals |
| 07/01/2004 | WO2004054356A2 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 07/01/2004 | WO2004037849A3 Transgenic non-human animals with expanded mature b cell and plasma cell populations |
| 07/01/2004 | WO2004018512A3 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 07/01/2004 | WO2003106694A3 Rapid methods for assessing therapeutic activity using animals expressing constitutively active g protein-coupled receptors |
| 07/01/2004 | WO2003083072A3 In vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of disease states |
| 07/01/2004 | WO2003078600A3 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 07/01/2004 | US20040128708 Transgenic rodent encoding nucleotide sequences coding melanin concentrating hormone type 1 receptor for use in treatment of sleep and eating disorders |
| 07/01/2004 | US20040128707 Animal model for pancreatic disorder associated with signal transduction; obesity prevention |
| 07/01/2004 | US20040128706 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 07/01/2004 | US20040128705 Stearoyl CoA desaturase transgenic non-human animals |
| 07/01/2004 | US20040128703 DNA construct containing a human DNA sequence flanked by sequences from the non-human animal is generated by recombination in a bacterial cell, DNA construct that is produced can then be introduced into a non-human embryogenic stem cell |
| 07/01/2004 | US20040127686 Signal transduction regulator binding protein for identifying modulators for prevention and treatment of cardiomyopic hypertrophy, heart failure and diabetes; drug screening |
| 07/01/2004 | US20040127444 modulating chromatin structure, the method comprising altering expression of PARP-e |
| 07/01/2004 | US20040126885 Delivery vehicle for recombinant proteins |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 07/01/2004 | CA2509583A1 Methods and vectors for making knockout animals |
| 07/01/2004 | CA2509333A1 Method for generating a genetically modified organism for screening active substances |
| 06/30/2004 | EP1432990A2 Diabetic model |
| 06/30/2004 | EP1432819A2 Method for determining cell cycle position |
| 06/30/2004 | EP1432794A2 Human coagulation factor vii polypeptides |
| 06/30/2004 | EP1432736A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 06/30/2004 | EP1432732A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/30/2004 | EP1432722A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 06/30/2004 | EP1365643A4 Microinjection assembly and methods for microinjecting and reimplanting avian eggs |
| 06/30/2004 | EP0915902A4 Transgenic animals expressing artificial epitope-tagged proteins |
| 06/30/2004 | EP0914419B1 Transgenic mice capable of expressing leukemia inhibitory factor |
| 06/30/2004 | EP0862628B1 Receptor and nucleic acid molecule encoding said receptor |
| 06/30/2004 | EP0686161B1 Novel human beta2 integrin alpha subunit |
| 06/29/2004 | US6756227 Used as prophylactic and/or therapeutic agents and polypeptides in medicine |
| 06/24/2004 | WO2004053119A1 Fluorescent proteins from aquatic species |
| 06/24/2004 | WO2004053090A2 Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer |
| 06/24/2004 | WO2004052118A1 Fish feed |
| 06/24/2004 | WO2004052094A1 Method to treat conditions associated with insulin signaling dysregulation |
| 06/24/2004 | WO2004052093A1 METHOD OF CONSTRUCTING NONHUMAN MAMMAL HAVING RNAi PHENOTYPE |
| 06/24/2004 | WO2004007753A3 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| 06/24/2004 | WO2004005474A3 A robust, inducible cardiac preferred expression system for transgenesis |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003047336A3 TRANSGENIC ANIMALS BEARING HUMAN Igμ LIGHT CHAIN GENES |
| 06/24/2004 | WO2002092758A9 Gastrokines and derived peptides including inhibitors |
| 06/24/2004 | US20040123335 Using peptide mimetics to prevent or treat autoimmune diseases; immunotherapy |
| 06/24/2004 | US20040123334 Methods of treating neurodegenerative diseases |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121368 having genetic aptitudes beneficial to people such as seeing-eye dogs, disaster rescue dogs, assisting dogs, narcotics detection dogs, watchdogs, and pet dogs; kits |
| 06/24/2004 | US20040121303 includes cooling the sperm to a first temperature; maintaining the sperm sample at the first temperature; cooling the sperm to a second temperature; maintaining the sperm at the second temperature; and storing the sperm at a third temperature |
| 06/24/2004 | US20040120945 Cell surface molecule mediating cell adhesion and signal transmission |
| 06/24/2004 | US20040120934 Cloned ungulate embryos and animals, use of cells tissues and organs thereof for transplantation therapies including parkinson's disease |
| 06/24/2004 | CA2509465A1 Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer |
| 06/24/2004 | CA2509373A1 Fluorescent proteins from aquatic species |
| 06/23/2004 | EP1431307A1 Inactive transcription factor TIF-IA and uses thereof |
| 06/23/2004 | EP1430126A1 Dna sequences for human angiogenesis genes |
| 06/23/2004 | EP1430125A2 Sperm-specific cation channel, and uses therefor |
| 06/23/2004 | EP1430124A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 06/23/2004 | EP1430123A2 A method for generating hypermutable organisms |
| 06/23/2004 | EP1430122A2 Non-human animal model for analysis of the origin and therapy of organ fibrosis |
| 06/23/2004 | EP1429600A2 An invertebrate animal model with alzheimer-like pathology for screening and testing molecules |
| 06/23/2004 | EP1131411B1 Suppression of xenotransplant rejection |
| 06/23/2004 | EP1122997B1 Method for localizing allantoic fluid of avian eggs |